tert-butyl 3-azabicyclo[3.1.0]hex-6-ylmethylcarbamate | 871727-12-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: tert-butyl 3-azabicyclo[3.1.0]hex-6-ylmethylcarbamate
• 英文别名: tert-Butyl ((3-azabicyclo[3.1.0]hexan-6-yl)methyl)carbamate；tert-butyl N-(3-azabicyclo[3.1.0]hexan-6-ylmethyl)carbamate
• CAS: 871727-12-7
• 化学式: C₁₁H₂₀N₂O₂
• 分子量: 212.292
• InChiKey: JXWGBEYMMHSBFU-UHFFFAOYSA-N

物化性质

• 沸点：
  321.9±15.0 °C(Predicted)
• 密度：
  1.064±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  50.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  tert-butyl 3-azabicyclo[3.1.0]hex-6-ylmethylcarbamate 、 2-甲砜基-5-嘧啶甲酸乙酯 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 0.5h， 以90%的产率得到ethyl 2-(6-{[(tert-butoxycarbonyl)amino]methyl}-3-azabicyclo[3.1.0]hex-3-yl)pyrimidine-5-carboxylate
  参考文献：
  名称：

  Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a Class I Selective Orally Active Histone Deacetylase Inhibitor

  摘要：

  A novel series of HDAC inhibitors demonstrating class I subtype selectivity and good oral bioavailability is described. The compounds are potent enzyme inhibitors (IC50 values less than 100 nM), and improved activity in cell proliferation assays was achieved by modulation of polar surface area (PSA) through the introduction of novel linking groups. Employing oral pharmacokinetic studies in mice, comparing drug levels in spleen to plasma, we selected compounds that were tested for efficacy in human tumor xenograft studies based on their potential to distribute into tumor. One compound, 21r (CHR-3996), showed good oral activity in these models, including dose-related activity in a LoVo xenograft. In addition 21r showed good activity in combination with other anticancer agents in in vitro studies. On the basis of these results, 21r was nominated for clinical development.

  DOI：

  10.1021/jm101177s
• 作为产物：
  描述：

  tert-butyl (3-benzyl-3-azabicyclo[3.1.0]hex-6-yl)methylcarbamate 在 palladium 10% on activated carbon 甲酸铵 作用下， 以 乙醇 为溶剂， 反应 2.0h， 以73%的产率得到tert-butyl 3-azabicyclo[3.1.0]hex-6-ylmethylcarbamate
  参考文献：
  名称：

  WO2006/123121

  摘要：

  公开号：

文献信息

• FATTY ACID MYCOPHENOLATE DERIVATIVES AND THEIR USES
  申请人：Milne Jill C.

  公开号：US20110213028A1

  公开（公告）日：2011-09-01

  The invention relates to fatty acid mycophenolate derivatives; compositions comprising an effective amount of a fatty acid mycophenolate derivative; and methods for treating and preventing organ rejection and autoimmune diseases such as systemic lupus erythematosus, psoriasis and multiple sclerosis comprising the administration of an effective amount of a fatty acid mycophenolate derivative.

  该发明涉及脂肪酸霉酚酸酯衍生物；包含有效量脂肪酸霉酚酸酯衍生物的组合物；以及治疗和预防器官排斥和自身免疫疾病，如系统性红斑狼疮、牛皮癣和多发性硬化症的方法，包括给予有效量脂肪酸霉酚酸酯衍生物的管理。
• FATTY ACID FUMARATE DERIVATIVES AND THEIR USES
  申请人：Milne Jill C.

  公开号：US20110172240A1

  公开（公告）日：2011-07-14

  The invention relates to Fatty Acid Fumarate Derivatives; compositions comprising an effective amount of a Fatty Acid Fumarate Derivative; and methods for treating or preventing cancer, a metabolic disorder or neurodegenerative disorder comprising the administration of an effective amount of a Fatty Acid Fumarate Derivative.

  这项发明涉及脂肪酸富马酸酯衍生物；包含有效量脂肪酸富马酸酯衍生物的组合物；以及治疗或预防癌症、代谢紊乱或神经退行性疾病的方法，包括给予有效量脂肪酸富马酸酯衍生物。
• [EN] FATTY ACID GAMMA AMINOBUTYRIC ACID (GABA) CONJUGATES AND THEIR USES<br/>[FR] CONJUGUÉS D'ACIDE GRAS ET D'ACIDE GAMMA-AMINOBUTYRIQUE (GABA) ET LEURS APPLICATIONS
  申请人：CATABASIS PHARMACEUTICALS INC

  公开号：WO2012161798A1

  公开（公告）日：2012-11-29

  The invention relates to fatty acid GABA conjugates; compositions comprising an effective amount of a fatty acid GABA conjugate; and methods for treating or preventing a metabolic disease or an inflammatory disorder comprising the administration of an effective amount of a fatty acid GABA conjugate.

  该发明涉及脂肪酸GABA共轭物；包含有效量脂肪酸GABA共轭物的组合物；以及用于治疗或预防代谢性疾病或炎症性疾病的方法，包括给予有效量脂肪酸GABA共轭物。
• [EN] FATTY ACID ANTICANCER DERIVATIVES AND THEIR USES<br/>[FR] DÉRIVÉS D'ACIDES GRAS ANTI-CANCÉREUX ET LEURS UTILISATIONS
  申请人：CATABASIS PHARMACEUTICALS INC

  公开号：WO2014204856A1

  公开（公告）日：2014-12-24

  The invention relates to fatty acid anticancer derivatives; compositions comprising an effective amount of a fatty acid anticancer derivative; and methods for treating or preventing cancer comprising the administration of an effective amount of a fatty acid anticancer derivative.

  这项发明涉及脂肪酸抗癌衍生物；包含有效量脂肪酸抗癌衍生物的组合物；以及治疗或预防癌症的方法，包括给予有效量脂肪酸抗癌衍生物的管理。
• [EN] FATTY ACID PHENOLIC DERIVATIVES AND THEIR USES<br/>[FR] DÉRIVÉS PHÉNOLIQUES D'ACIDES GRAS ET LEURS UTILISATIONS
  申请人：CATABASIS PHARMACEUTICALS INC

  公开号：WO2012154564A1

  公开（公告）日：2012-11-15

  The invention relates to fatty acid phenolic derivatives; compositions comprising an effective amount of a fatty acid phenolic derivative; and methods for treating or preventing a metabolic disease comprising the administration of an effective amount of a fatty acid phenolic derivative.

  这项发明涉及脂肪酸酚衍生物；包含有效量脂肪酸酚衍生物的组合物；以及治疗或预防代谢性疾病的方法，包括给予有效量脂肪酸酚衍生物的管理。